Novavax, Inc. - Common Stock (NQ:NVAX)

10.96 +0.50 (+4.83%)

Delayed Quote Updated: 12:36 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

68 69 Next >

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

September 06, 2024

Here's a look at five stocks that saw increased attention from Benzinga readers during the week and the reasons why.

Via Benzinga

Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again? ↗

September 05, 2024

Regulators recently approved an updated COVID shot from Novavax.

Via The Motley Fool

How Is The Market Feeling About Novavax? ↗

September 04, 2024

Via Benzinga

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

Via FinancialNewsMedia

Looking Into Novavax's Recent Short Interest ↗

August 16, 2024

Via Benzinga

Market Whales and Their Recent Bets on NVAX Options ↗

July 26, 2024

Via Benzinga

What's Going On With Novavax Shares Today? ↗

July 25, 2024

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday. Here's what you need to know.

Via Benzinga

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

September 04, 2024

From FN Media Group LLC

Via GlobeNewswire

Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday ↗

September 03, 2024

Via Benzinga

Looking Into Novavax's Recent Short Interest ↗

July 24, 2024

Via Benzinga

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 03, 2024

Via Benzinga

FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants ↗

September 03, 2024

The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The vaccine, included in CDC recommendations, will soon be available nationwide....

Via Benzinga

Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy? ↗

August 24, 2024

Don't be too quick to jump on the Wall Street bandwagon.

Via The Motley Fool

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot ↗

August 22, 2024

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new formulas from Moderna and Pfizer/BioNTech. These vaccines, designed to...

Via Benzinga

Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? ↗

August 19, 2024

Its 12-month relative strength performance is impressive, but Novavax now faces resistance.

Via Investor's Business Daily

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch ↗

August 19, 2024

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.

Via Benzinga

Topics ETFs

Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?

August 19, 2024

Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release.

Via MarketBeat

Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?

August 12, 2024

Novavax Inc. (NASDAQ: NVAX) is a biotechnology company that focuses on developing and commercializing vaccines for serious infectious diseases.

Via MarketBeat

COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit ↗

August 08, 2024

Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $0.99, below expectations. The company revised its 2024 revenue guidance to...

Via Benzinga

NVAX Stock Earnings: Novavax Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

NVAX stock results show that Novavax missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Wall Street's Top 10 Stock Calls This Week - Saturday, Aug. 3 ↗

August 03, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of July 29 through Aug. 2.

Via Talk Markets

Where Will Novavax Be in 5 Years? ↗

August 03, 2024

Its been a good year so far for the biotech, but how long can it keep the momentum going?

Via The Motley Fool

What's Going On With Novavax (NVAX) Stock? ↗

August 01, 2024

Novavax shares are trading lower by 5.5% Thursday morning. Shares of several vaccine makers are trading lower after Moderna revised its 2024 expectations.

Via Benzinga

Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat ↗

August 01, 2024

Moderna delivered nearly double the sales analysts expected in the second quarter.

Via Investor's Business Daily

JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024 ↗

July 31, 2024

Analysts from JPMorgan Chase have expressed their concern about the outlook for these stocks with lowered price targets.

Via InvestorPlace

JPMorgan Just Issued a Warning on Novavax (NVAX) Stock ↗

July 30, 2024

Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns.

Via InvestorPlace

Stocks Mixed After Job Openings, Consumer Data ↗

July 30, 2024

Stocks are mixed midday, as the Federal Reserve's two-day policy meeting gets underway, with plenty of earnings and economic data for Wall Street to unpack in the meantime.

Via Talk Markets

Topics Economy

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 30, 2024

Via Benzinga

Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 30, 2024

Via Benzinga

Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

July 30, 2024

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.